| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5912165 | Multiple Sclerosis and Related Disorders | 2016 | 16 Pages |
Abstract
The effect of fingolimod on diffuse damage is partly independent of its treatment effect on focal damage, suggesting that both inflammatory and neurodegenerative components of MS are affected.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Genetics
Authors
Nicola De Stefano, Davorka Tomic, Ernst-Wilhelm Radue, Till Sprenger, Daniela Piani Meier, Dieter Häring, Maria Pia Sormani,